Evidence map›Paper›PMID 38074891›Full record

ReviewHeliyon2023

A review of pomegranate supplementation: A promising remedial avenue for Alzheimer's disease.

Aman Ullah, Asif Khan, Sagheer Ahmed, Hafiz Muhammad Irfan, Amin A Hafiz, Kainat Jabeen, Mubarak Alruwaili, Muteb Alotaibi, Waiel Al Naeem, Ajmal Khan and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 5 countries.

Aman UllahDepartment of Pharmacy, Saba Medical Center, Abu Dhabi P.O. Box 20316, United Arab Emirates.
Asif KhanLaboratory of Phytochemistry, Department of Botany, University of São Paulo, São Paulo Brazil. 05508-090.
Sagheer AhmedShifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad 44000, Pakistan.
Hafiz Muhammad IrfanCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Amin A HafizDepartment of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al- Qura University, Kingdom of Saudi Arabia.
Kainat JabeenCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Mubarak AlruwailiDepartment of Internal Medicine, College of Medicine, Jouf University, Sakaka, Saudi Arabia.
Muteb AlotaibiPrince sultan military medical city, Riyadh Saudi Arabia.
Waiel Al NaeemClinical Pharmacy Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Ajmal KhanNatural and Medical Sciences Research Center, University of Nizwa, P.O Box 33, Postal Code 616, Birkat Al Mauz, Nizwa, Sultanate of Oman.
Ahmed Al-HarrasiNatural and Medical Sciences Research Center, University of Nizwa, P.O Box 33, Postal Code 616, Birkat Al Mauz, Nizwa, Sultanate of Oman.
Universidade de São Paulo · BRUniversity of Sargodha · PKJouf University · SARiyadh Armed Forces Hospital · SAShaikh Khalifa Medical City · AEShifa Tameer-e-Millat University · PKUmm al-Qura University · SAUniversity of Nizwa · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative complications, like Alzheimer's disease (AD) exert adverse effects i.e. psychological and physiological in the central nervous system. The synthetic drugs used for these complications have negative effects on body health and therefore natural remedies are a good and targeted approach to counter such complications. Alternatively, fruits and a variety of biochemicals which are an important source of diet, can be used for remedial purposes. Due to the antioxidant properties of polyphenolic compounds, several companies utilize this property to advertise polyphenol-rich beverages. Pomegranate (

Indexed as

Alzheimer diseaseAntioxidantNerve disorderPhytochemicalsPomegranate

Identifiers

PMID38074891
PMCPMC10700657
OpenAlexW4388713755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.